111 (YI) Moat Score: 4/10 (As of Jul. 03, 2026)


YI 111 Inc YI
51 GF Score
Price $4.21
GF Value $6.66
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is 111 Moat Score?

111 YI -0.24% 51 Moat Score is 4 as of Jul. 03, 2026. GuruFocus rates YI with a GF Score™ of 51/100 and a GF Value™ of $6.66 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 119 Medical Distribution companies, 111 ranks better than 89.92% on this metric.

111 has the Moat Score of 4, which implies that the company might have Narrow Moat - Discernible but modest moat.

111 has Narrow Moat: 111 Inc has a discernible but modest moat due to its position in China's online healthcare market. It benefits from a growing customer base and some brand recognition. However, it faces intense competition and lacks significant switching costs or proprietary technology, limiting its moat strength.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes 111 might have Narrow Moat - Discernible but modest moat.

111  (NAS:YI) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

111 Moat Score Related Terms

YI vs COSM, HKPD, SNYR: Moat Score Comparison

For the Medical Distribution subindustry, 111's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

111 Moat Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, 111's Moat Score distribution charts can be found below:

* The bar in red indicates where 111's Moat Score falls into.


YI
51GF Score
111 Inc YI
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 4 mean?
111 (YI) has a Moat Score of 4 as of Jul. 03, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, 111 ranks #12 out of 119 companies in the Medical Distribution industry, placing it in the top 10.1%.
Is 111's Moat Score too high?
111's current Moat Score is 4. Based on the distribution chart, 111 ranks #12 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, 111 has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does 111's Moat Score compare to COSM and HKPD?
According to the Medical Distribution industry distribution chart, 111 ranks #12 out of 119 companies for Moat Score. This places 111 in the top 10% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Distribution company?
A good Moat Score depends on the Medical Distribution industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. 111's current Moat Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 111 stock overvalued right now?
Based on GuruFocus' analysis, 111 (YI) is currently considered Possible Value Trap. The stock's GF Value™ is $6.66, compared to a current price of $4.21 — trading 36.9% below its estimated fair value. The current Moat Score is 4. 111's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For 111 (YI), the current Moat Score is 4 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 111 (YI) Overvalued in 2026?

Based on GuruFocus' analysis, 111 stock appears to be undervalued. The current stock price of $4.21 is trading 36.9% below its estimated GF Value™ of $6.66. GuruFocus considers 111 to be Possible Value Trap.

Key valuation signals for YI:

  • Moat Score: 4
  • GF Value™: $6.66 vs. price of $4.21 (36.9% below fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the YI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

111 Business Description

Other Exchanges 811A:Germany
Address No.268 Yubei Road, 10th Floor, T1, Yuzhongxin, Pudong New Area, Shanghai, CHN, 201204
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.
51GF Score

Get the complete analysis for YI

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.21
Price
$6.66
GF Value